Ticker Details
Lantheus Holdings, Inc. Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray imaging.
IPO Date:	June 25, 2015
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$5.3B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.78 | 2.28%
Avg Daily Range (30 D):	$1.64 | 2.14%
Avg Daily Range (90 D):	$1.10 | 1.55%

Institutional Daily Volume
Avg Daily Volume:	.58M
Avg Daily Volume (30 D):	.86M
Avg Daily Volume (90 D):	.74M

Trade Size
Avg Trade Size (Sh.):	64
Avg Trade Size (Sh.) (30 D):	50
Avg Trade Size (Sh.) (90 D):	45

Institutional Trades
Total Institutional Trades:	5,936
Avg Institutional Trade:	$3.47M
Avg Institutional Trade (30 D):	$5.89M
Avg Institutional Trade (90 D):	$5.56M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$5.94M
Avg Closing Trade (30 D):	$12.63M
Avg Closing Trade (90 D):	$10.89M
Avg Closing Volume:	106.89K

News

Feb 26, 2026 @ 12:00 PM Lantheus Reports Fourth Quarter and Full Year 2025... Source: Na

Feb 20, 2026 @ 3:55 PM PSMA-Targeted Therapy & Radiodiagnostics Competito... Source: Researchandmarkets.Com

Feb 12, 2026 @ 1:00 PM Lantheus to Host Fourth Quarter and Full Year 2025... Source: Na

Jan 2, 2026 @ 1:00 PM Lantheus Announces Closing of SPECT Business Sale ... Source: Na

Dec 23, 2025 @ 11:25 PM Lantheus Exit: $28 Million Sale Comes as Earnings ... Source: Jonathan Ponciano

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$3.46	$.83	$3.46
Diluted EPS	$3.41	$.81	$3.41
Revenue	$1.54B	$406.79M	$1.54B
Gross Profit	$941.95M	$240.88M	$941.95M
Net Income / Loss	$233.56M	$54.09M	$233.56M
Operating Income / Loss	$310.83M	$77.18M	$310.83M
Cost of Revenue	$599.66M	$165.91M	$599.66M
Net Cash Flow	$-553.66M	$-22.88M	$-553.66M
PE Ratio	23.63